News und Analysen
Augmedix is an ambient AI healthcare optimization play
Augmedix Inc. (NASDAQ: AUGX) is an artificial intelligence (AI) powered ambient medical documentation solutions provider in the medical sector. It utilizes generative AI for documenting medical
Sprinklr: Has the smoke cleared to buy back in?
Sprinklr Inc. (NYSE: CXM) offers a cloud-based unified customer experience management (unified-CXM) platform. As a member of the business services sector, Sprinklr enables companies to manage all
Eilt: Hautkrebs vollständig geheilt - Ausbruch Massives Kaufsignal. Neuer 175% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Hautkrebs vollständig geheilt - Massives Kaufsignal. Neuer 175% Biotech Aktientip nach 15973% mit BioNTech ($BNTX)
09.01.24 08:02
London (www.aktiencheck.de, Anzeige)
Boeing stock gaps down 8.50% on new round of 737 Max woes
Shares of The Boeing Co. (NYSE: BA) gapped down 8.50% at the open on January 8, after a panel from an Alaska Air Group Inc. (NYSE: ALK) fell out mid-flight.
The plane made an emergency landing
Merck, the Dow's hottest stock, gets set to report Q4 financials
Dow Jones Industrial Average (DJIA) stalwart Merck & Co., Inc. (NYSE:MRK) has momentum on its side heading into its February 1st earnings report.
Shares of the large cap pharmaceutical company
Spirit AeroSystems stock will rally on Boeing's new orders
Everyone is focused on the popularity of following Boeing (NYSE: BA) and its recent development in new orders. After years of being compressed below any reasonable fairness, its stock is finally
Bank of America and Citigroup are banking stocks that could soar
Who likes to invest in financial stocks? Only people with a solid financial or accounting background, since they can reasonably understand the balance sheets and valuations of these stocks well
Apple stock at a crossroads, is now the time to buy?
Apple Inc. (NASDAQ: AAPL) stands as a towering figure in the world of stocks and investments, a testament to the power of innovation and resilience in the tech industry. However, recent price
2 low-priced gene therapy stocks to speculate on
Gene therapy differs from gene editing, which is getting the lion's share of headlines. While gene editing is a form of gene therapy, there are basic differences. Gene-editing involves using
There's a new buy signal flashing for these stocks, Dalio effect?
In every market, there are markers and yardsticks - or benchmarks as they like to call them - that attract investment dollars in and out of specific vehicles and asset classes. Focusing on stocks
3 Magnificent Seven stocks are approaching potential buy zones
As the year begins and capital begins to be put to work, a new chapter is unfolding for members of the heralded 'Magnificent Seven.' As the curtains rise in 2024, these tech behemoths, the guiding
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. Neuer 200% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB)
Eilt: Ausbruch - Massives Kaufsignal - Hautkrebs vollständig geheilt. 200% Biotech Hot Stock nach 134.452% mit Biogen
08.01.24 08:03
London (www.aktiencheck.de , Anzeige)
Are defensive sectors ready to outshine growth in 2024?
Defensive sectors are off to a better start to the new year than growth stocks, which dominated in 2023.
The Health Care Select Sector SPDR Fund (NYSEARCA: XLV), which has both growth and
Are top upgrades Micron, Lululemon & CrowdStrike buys right now?
Micron Technology, Inc. (NASDAQ: MU), Lululemon Athletica Inc. (NASDAQ: LULU) and CrowdStrike Holdings Inc. (NASDAQ: CRWD) made MarketBeat’s list of most upgraded stocks in the past 90 days. Does
This biotech stock has surged over 300% this week
As the market continues to witness a resurgence in small-cap investments, led by a jump in investor optimism and speculation, there’s been a seemingly steady flow of capital back into
The 5 top-rated dividend stocks by analysts
Marketbeat.com provides many tools for investors, including analyst-tracking algorithms. A single upgrade is worthless, but a trend of upgrades can repeatedly drive a stock to new highs. Today
Can Coinbase stock still rally another 50% from here?
Coinbase Global Inc. (NASDAQ: COIN) is the largest publicly traded cryptocurrency exchange in the U.S. It is arguably the most trusted and stable exchange due to its regulatory transparency and
Will the Biotech sector sustain its momentum in 2024?
The stock market is like a bustling stage, and on the first trading day of the year, one performer stole the show while others struggled to keep up.
Is Netflix stock a buy ahead of January earnings?
Even though a 75% drop through 2022 may have disqualified Netflix Inc (NASDAQ: NFLX) from the previously untouchable FAANG group of tech stocks, the current rally of nearly 200% has certainly put
It's official, BYD has overtaken Tesla as the EV king
What a time to be an investor; there are changes coming left and right to those who call the stock market home to their savings or spare cash to be invested. The intellectual challenge is enough
Analysts expect Bank of America stock to rally 55%
A 35% rally since October meant that Bank of America (NYSE: BAC) shares finished the year on a high after what was, at best, turning into a mediocre year before that. Shares of the Wall Street
3 ways to trade options if you believe a stock will fall lower
If you believe that a stock is going to fall lower in price, then there are three kinds of options trades you can make to capitalize on the move potentially. You don't necessarily have to be a
3 mid-cap stocks that analysts love heading into earnings season
The beginning of a new year also means that a new earnings season is right around the corner. Every earnings season seems "the most important earnings season" for investors. But when every stock
Eilt: Sensationeller Durchbruch im Kampf gegen den Hautkrebs - Massives Kaufsignal. 297% Biotech Hot Stock nach 3.296% mit BioNTech ($BNTX), 10.996% mit Pfizer ($PFE), 31.205% mit Amgen ($AMG) und 134.452% mit Biogen ($BIIB). Jetzt 359% mit Biotech
Eilt: Sensationeller Durchbruch im Kampf gegen den Hautkrebs. 279% Biotech Hot Stock nach 134.452% mit Biogen ($BIIB)
04.01.24 08:02
London (www.aktiencheck.de , Anzeige)